Form RW - Registration Withdrawal Request
05 February 2025 - 8:05AM
Edgar (US Regulatory)
Oragenics,
Inc.
1990
Main Street, Suite 750
Sarasota,
Florida 34236
February
4, 2025
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549-3628
|
Re: |
Oragenics,
Inc. (the “Company”) |
|
|
Request
to Withdraw Registration Statement on Form S-1 |
|
|
Filed
on December 18, 2024 |
|
|
File
No. 333-283927 |
Ladies
and Gentlemen:
Pursuant
to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Oragenics, Inc. (the “Registrant”)
hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal,
effective as of the date hereof or at the earliest practicable date hereafter, of the Registrant’s Registration Statement on Form
S-1 (File No. 333-283927) filed with the Commission on December 18, 2024, together with all amendments and exhibits thereto (collectively,
the “Registration Statement”), effective as of the date hereof.
The
Registrant has decided not to pursue the offering due to business decisions and confirms that no securities covered by the Registration
Statement have been issued or sold. Based on the foregoing, the Registrant submits that the withdrawal of the Registration Statement
is consistent with the public interest and the protection of investors.
Pursuant
to Rule 477(b) under the Securities Act, the Registrant understands that this request for withdrawal of the Registration Statement will
be deemed granted as of the date hereof, unless the Registrant receives notice from the Commission within 15 days of the date hereof
that such request will not be granted. In accordance with Rule 457(p) under the Securities Act, the Registrant requests that all fees
paid to the Commission in connection with the filing of the Registration Statement be credited to the Registrant’s account for
future use.
We
appreciate your time and attention to this matter. Should you have any questions, please call our counsel, Julio Esquivel, of Shumaker,
Loop & Kendrick, LLP, at (813) 227-2325.
|
Very
truly yours, |
|
|
|
|
By: |
/s/Janet
Huffman |
|
Name: |
Janet
Huffman |
|
Title: |
Chief
Financial Officer |
c:
Julio C. Esquivel, Shumaker, Loop & Kendrick, LLP
Oragenics (AMEX:OGEN)
Historical Stock Chart
From Jan 2025 to Feb 2025
Oragenics (AMEX:OGEN)
Historical Stock Chart
From Feb 2024 to Feb 2025